Form 4 for ORIC Oric Pharmaceuticals, Inc.
Accepted 2026-02-26 00:00:00 ET · period of report 2026-02-24 · accession 0001695028-26-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-02-26 | 2026-02-24 | ORIC | Piscitelli Dominic | CFO | S - Sale+OE | $13.51 | -52.0K | 68.1K | -43% | -$702.5K |
| D | 2026-02-26 | 2026-02-24 | ORIC | Piscitelli Dominic | CFO | M - OptEx | $4.36 | +52.0K | 120.1K | +76% | +$226.7K |
| D | 2026-02-26 | 2026-02-24 | ORIC | Piscitelli Dominic | CFO | M - OptEx | $0.00 | -52.0K | 144.5K | -26% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-24 | S | D | 52,000 | $13.51 | 68,148 | D | — | — | (F2) Represents the weighted average share price of an aggregate total of 52,000 shares sold in the price range of $13.50 to $13.53 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 2 | Common | Common Stock | 2026-02-24 | M | A | 52,000 | $4.36 | 120,148 | D | — | — | |
| 3 | Derivative | Stock Option (right to buy) | 2026-02-24 | M | D | 52,000 | $0.00 | 144,500 | D | $4.36 · 2025-07-20 to 2032-07-19 | 52,000 Common Stock |